# NKX6-1

## Overview
NKX6-1 is a gene that encodes the NK6 homeobox 1 protein, a transcription factor primarily involved in the regulation of pancreatic β-cell development and function. The NK6 homeobox 1 protein is characterized by a homeodomain, which facilitates its binding to specific DNA sequences, thereby influencing the transcription of genes critical for insulin biosynthesis and glucose metabolism (Jørgensen1999Cloning; Mirmira2000βCell). This protein plays a pivotal role in maintaining β-cell identity by repressing alternative endocrine lineage programs and is essential for glucose-stimulated insulin secretion (Taylor2013Nkx6.1; Aigha2020NKX6.1). Beyond its role in normal physiology, NKX6-1 is implicated in various pathological conditions, including diabetes and cancer, where its expression levels can influence disease progression and prognosis (Li2015NKX6.1; Aigha2020NKX6.1).

## Structure
The NKX6-1 protein is a transcription factor characterized by a homeodomain, a conserved DNA-binding domain typically comprising 60 amino acids forming a helix-turn-helix structure. This homeodomain is crucial for its role in binding to specific DNA sequences, such as the consensus sequence TTAATTAC, which is important for its function in pancreatic β-cell differentiation (Jørgensen1999Cloning; Mirmira2000βCell).

The protein also contains a COOH-terminal domain, which acts as a DNA binding interference domain (BID). This region, spanning amino acids 306-364, negatively regulates DNA binding by interfering with the homeodomain's interaction with DNA. The BID is characterized by a stretch of acidic amino acids, which may disrupt the interaction between the DNA binding domain and the DNA's phosphate backbone (Mirmira2000βCell).

The C-terminal domain of NKX6-1 enhances DNA binding selectivity at the insulin promoter, particularly through a conserved stretch of residues between amino acids 318 and 338. This domain does not significantly alter the secondary structure of the unbound protein but enhances sequence-selective DNA binding when fused to other homeodomains (Taylor2005The). 

NKX6-1 may undergo post-translational modifications, such as phosphorylation, which can influence its activity and stability. Alternative splicing can result in different isoforms, potentially affecting its regulatory roles.

## Function
The NKX6-1 gene encodes a transcription factor that is crucial for the development, identity, and function of pancreatic β cells. It plays a significant role in the differentiation of these cells by acting as both a transcriptional repressor and activator, depending on the DNA context. NKX6-1 binds to specific DNA sequences, including a TAAT core, to regulate the expression of genes involved in insulin biosynthesis, glucose metabolism, and β cell proliferation (Aigha2020NKX6.1; Mirmira2000βCell; Iype2004The).

In healthy human cells, NKX6-1 maintains β cell identity by repressing alternative endocrine lineage programs, such as those leading to α cell development, through the inhibition of genes like GCG (Aigha2020NKX6.1). It also regulates the expression of key genes involved in insulin processing and secretion, such as Slc30a8 and Ero1lb, and is essential for glucose-stimulated insulin secretion (Taylor2013Nkx6.1; Aigha2020NKX6.1).

NKX6-1 is active in the nucleus, where it modulates the transcription of target genes, impacting cell fate and organogenesis. Its expression is regulated by factors like PDX1 and NGN3, and it functions downstream of NKX2.2 in the β cell differentiation pathway (Aigha2020NKX6.1).

## Clinical Significance
Alterations in the expression of the NKX6-1 gene have significant clinical implications, particularly in the context of diabetes and cancer. In diabetes, decreased expression of NKX6-1 is linked to the development of type 2 diabetes (T2D) in humans and rodents. This is due to its role in regulating pancreatic β cell proliferation and glucose-stimulated insulin secretion. Variants of NKX6-1 have been associated with T2D in East Asian populations through genome-wide association studies. Loss of NKX6-1 expression can lead to rapid-onset diabetes due to defects in insulin biosynthesis and secretion, affecting genes like Slc30a8 and Pcsk1, which are associated with T2D (Aigha2020NKX6.1).

In cancer, NKX6-1 plays a dual role. It acts as a metastasis suppressor by inhibiting the epithelial-to-mesenchymal transition (EMT), a process critical for cancer metastasis. Low NKX6-1 expression is associated with high metastasis in clinical cancer tumors, and its hypermethylation is observed in acute lymphoblastic leukemia and cervical cancer, suggesting its potential as a biomarker (Li2015NKX6.1). Conversely, in leiomyosarcoma (LMS), high NKX6-1 expression is linked to poor prognosis and increased malignancy, as it promotes cancer stem-like properties and regulates the Sonic Hedgehog (SHH) and NOTCH signaling pathways (Su2021NKX61).

## Interactions
NKX6-1 is a transcription factor that engages in various interactions with proteins and nucleic acids, playing a crucial role in gene regulation. It binds to the distal region of the HNF1α promoter in pancreatic beta cells, a mechanism distinct from its regulation in hepatocytes, and this binding is confirmed through EMSA and ChIP assays (Donelan2010Distinct). NKX6-1 also interacts with the glucagon promoter, where it competes with PAX6 for the G1 element, inhibiting glucagon expression (Gauthier2007The).

In pancreatic β-cell differentiation, NKX6-1 functions as both a transcriptional activator and repressor, with its activity being sequence-dependent. It can activate transcription of its own gene, suggesting a feedback loop mechanism (Iype2004The). NKX6-1 interacts with enhancer-like elements in the promoters of cyclin A2 and B1, indicating its role in cell cycle regulation (Schisler2008Stimulation).

In cancer, NKX6-1 interacts with epigenetic modifiers such as BAF155 and RBBP7. It recruits BAF155 to enhance E-cadherin expression and RBBP7 to repress vimentin expression, thereby modulating the epithelial-mesenchymal transition (Li2015NKX6.1). These interactions highlight NKX6-1's role in both maintaining pancreatic β-cell function and suppressing cancer metastasis.


## References


[1. (Aigha2020NKX6.1) Idil I. Aigha and Essam M. Abdelalim. Nkx6.1 transcription factor: a crucial regulator of pancreatic β cell development, identity, and proliferation. Stem Cell Research &amp; Therapy, October 2020. URL: http://dx.doi.org/10.1186/s13287-020-01977-0, doi:10.1186/s13287-020-01977-0. This article has 80 citations.](https://doi.org/10.1186/s13287-020-01977-0)

[2. (Jørgensen1999Cloning) Mette Christine Jørgensen, Helle Vestergård Petersen, Johan Ericson, Ole Dragsbæk Madsen, and Palle Serup. Cloning and dna‐binding properties of the rat pancreatic β‐cell‐specific factor nkx6.1. FEBS Letters, 461(3):287–294, November 1999. URL: http://dx.doi.org/10.1016/s0014-5793(99)01436-2, doi:10.1016/s0014-5793(99)01436-2. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0014-5793(99)01436-2)

[3. (Mirmira2000βCell) Raghavendra G. Mirmira, Hirotaka Watada, and Michael S. German. Β-cell differentiation factor nkx6.1 contains distinct dna binding interference and transcriptional repression domains. Journal of Biological Chemistry, 275(19):14743–14751, May 2000. URL: http://dx.doi.org/10.1074/JBC.275.19.14743, doi:10.1074/jbc.275.19.14743. This article has 79 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.275.19.14743)

[4. (Li2015NKX6.1) H-J Li, P-N Yu, K-Y Huang, H-Y Su, T-H Hsiao, C-P Chang, M-H Yu, and Y-W Lin. Nkx6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial–mesenchymal transition. Oncogene, 35(17):2266–2278, August 2015. URL: http://dx.doi.org/10.1038/onc.2015.289, doi:10.1038/onc.2015.289. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2015.289)

[5. (Su2021NKX61) Po-Hsuan Su, Rui-Lan Huang, Hung-Cheng Lai, Lin-Yu Chen, Yu-Chun Weng, Chih-Chien Wang, and Chia-Chun Wu. Nkx6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma. Journal of Biomedical Science, April 2021. URL: http://dx.doi.org/10.1186/s12929-021-00726-6, doi:10.1186/s12929-021-00726-6. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12929-021-00726-6)

[6. (Donelan2010Distinct) William Donelan, Vijay Koya, Shi-Wu Li, and Li-Jun Yang. Distinct regulation of hepatic nuclear factor 1α by nkx6.1 in pancreatic beta cells. Journal of Biological Chemistry, 285(16):12181–12189, April 2010. URL: http://dx.doi.org/10.1074/jbc.m109.064238, doi:10.1074/jbc.m109.064238. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.064238)

[7. (Taylor2013Nkx6.1) Brandon L. Taylor, Fen-Fen Liu, and Maike Sander. Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells. Cell Reports, 4(6):1262–1275, September 2013. URL: http://dx.doi.org/10.1016/j.celrep.2013.08.010, doi:10.1016/j.celrep.2013.08.010. This article has 269 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2013.08.010)

[8. (Taylor2005The) David G. Taylor, Daniella Babu, and Raghavendra G. Mirmira. The c-terminal domain of the β cell homeodomain factor nkx6.1 enhances sequence-selective dna binding at the insulin promoter. Biochemistry, 44(33):11269–11278, July 2005. URL: http://dx.doi.org/10.1021/bi050821m, doi:10.1021/bi050821m. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi050821m)

[9. (Gauthier2007The) Benoit R. Gauthier, Yvan Gosmain, Aline Mamin, and Jacques Philippe. The β-cell specific transcription factor nkx6.1 inhibits glucagon gene transcription by interfering with pax6. Biochemical Journal, 403(3):593–601, April 2007. URL: http://dx.doi.org/10.1042/bj20070053, doi:10.1042/bj20070053. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20070053)

[10. (Schisler2008Stimulation) Jonathan C. Schisler, Patrick T. Fueger, Daniella A. Babu, Hans E. Hohmeier, Jeffery S. Tessem, Danhong Lu, Thomas C. Becker, Bashoo Naziruddin, Marlon Levy, Raghavendra G. Mirmira, and Christopher B. Newgard. Stimulation of human and rat islet β-cell proliferation with retention of function by the homeodomain transcription factor nkx6.1. Molecular and Cellular Biology, 28(10):3465–3476, May 2008. URL: http://dx.doi.org/10.1128/MCB.01791-07, doi:10.1128/mcb.01791-07. This article has 131 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.01791-07)

[11. (Iype2004The) Tessy Iype, David G. Taylor, Suzanne M. Ziesmann, James C. Garmey, Hirotaka Watada, and Raghavendra G. Mirmira. The transcriptional repressor nkx6.1 also functions as a deoxyribonucleic acid context-dependent transcriptional activator during pancreatic β-cell differentiation: evidence for feedback activation of thenkx6.1gene by nkx6.1. Molecular Endocrinology, 18(6):1363–1375, June 2004. URL: http://dx.doi.org/10.1210/me.2004-0006, doi:10.1210/me.2004-0006. This article has 48 citations.](https://doi.org/10.1210/me.2004-0006)